Related Experiment Video
Updated: Aug 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Nevirapine-associated rash in a Jamaican child with HIV/AIDS
J C Steel-Duncan1, R Pierre, L Gabay
1The University of the West Indies, Kingston, Jamaica.
Insights
Nevirapine is a key HIV/AIDS treatment and prevention drug. Physicians should monitor for potential toxicities, such as the rash and systemic symptoms observed in an infant receiving nevirapine.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Nevirapine is a crucial first-line antiretroviral medication for treating HIV/AIDS.
- It is also utilized for preventing mother-to-child HIV transmission.
- Increasing availability necessitates awareness of antiretroviral drug toxicities.
Observation:
- A case report details an infant diagnosed with HIV.
- The infant exhibited a rash accompanied by systemic symptoms.
- These symptoms emerged during nevirapine treatment.
Findings:
- The infant's clinical presentation suggests a potential adverse reaction to nevirapine.
- This highlights the importance of recognizing drug-induced toxicities in pediatric HIV management.
Implications:
- Clinicians must be vigilant for adverse events associated with nevirapine therapy.
- Early recognition and management of toxicities are vital for patient outcomes.
- This case underscores the need for comprehensive monitoring in pediatric antiretroviral treatment.
Abstract:
Nevirapine is one of the first line antiretroviral agents used in the treatment of HIV/AIDS as well as for prophylaxis against mother-to-child transmission of HIV As antiretroviral medication becomes more available it is important for physicians to recognize the major clinical toxicities of these medications. We report a HIV-infected infant who developed a rash with systemic symptoms in association with nevirapine administration.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Retroviruses
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Genital Herpes
Hepatitis
